Georgia's Online Cancer Information Center

Standard Operating Procedures for Clinical Trials

SOP Title
   
General Administration (GA)
GA-101.02 SOP on SOPs: Preparing, Maintaining and Training
GA-102.02 Sponsor Responsibility and Delegation of Responsibility
GA-103.02 Training and Education
GA-104.01 Document Development and Change Control
   
Study Start-Up (SS)
SS-201.04 Assessing Protocol Feasibility
SS-202.01 Investigator Selection
SS-203.02 Pre-Study Site Visit (PSSV)
   
Study Management (SM)
SM-301.01 Communication
SM-303.02 Documentation and Records Retention
SM-304.01 Routine Monitoring Visits
SM-305.01 Closeout Visits
SM-306.01 Adverse Event Reporting
SM-307.01 Investigational Product Management
SM-308.02 Specimen Management
   
Data Management (DM)
DM-401.01 Data Management
   
Privacy Practices (PP)
PP-501.01 Safeguarding Protected Health Information
   
Quality Assurance (QA)
QA-601.02 FDA or Pharmaceutical Sponsored Audits
   

Last Updated: 2/18/2021 2:46:25 PM

Clinical Trials, Doctors & Cancer Centers

Georgia CORE wins $220,000 grant to support minority prostate cancer study

Georgia CORE has received Advancing Cancer Treatment's Community Engagement Grant for $220,000 to help recruit and provide navigation services for participation in the Prostate Cancer PROMISE study.

1/05/2023

This was the year: Georgia CORE's FY22 Annual Report

Click above, then for optimal viewing, hit the Fullscreen icon in the bottom right corner.

11/15/2022

 About

Georgia CORE releases report from Disparities in Cancer Clinical Trials Summit

On Sept. 30, Georgia's cancer experts shared advice and experiences with oncology providers, patient navigators and research managers - all to provide new ways to diversify participation in clinical trials. In February 2023, Georgia CORE issued a report with a recap and actions steps. Download the report >>

10/25/2022

Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.